Literature DB >> 18191547

In vitro effects of suramin on Trypanosoma cruzi.

Danielle Frias Ribeiro Bisaggio1, Camila Marques Adade, Thaïs Souto-Padrón.   

Abstract

Suramin has been previously reported to inhibit distinct cellular enzymes and to affect the synthesis and distribution of cytoskeleton proteins, cell differentiation and proliferation. The present study indicates that prolonged incubation of Trypanosoma cruzi-infected cells in the presence of 500 microM suramin during intracellular development of the parasite causes morphological changes in amastigote and trypomastigote forms related to the cell division and differentiation process. Our results also show that trypomastigotes obtained from suramin-treated host cells were significantly less infective than control parasites and that amastigotes derived from those trypomastigote forms were less proliferative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191547     DOI: 10.1016/j.ijantimicag.2007.11.001

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  6 in total

Review 1.  100 Years of Suramin.

Authors:  Natalie Wiedemar; Dennis A Hauser; Pascal Mäser
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

2.  Multiple effects of pepstatin A on Trypanosoma cruzi epimastigote forms.

Authors:  Leandro S Sangenito; Keyla C Gonçalves; Erika A Abi-Chacra; Cátia L Sodré; Claudia M d'Avila-Levy; Marta H Branquinha; André L S Santos
Journal:  Parasitol Res       Date:  2011-12-29       Impact factor: 2.289

3.  Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.

Authors:  Eliziária C Santos; Rômulo D Novaes; Marli C Cupertino; Daniel S S Bastos; Raphael C Klein; Eduardo A M Silva; Juliana L R Fietto; André Talvani; Maria T Bahia; Leandro L Oliveira
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

4.  Influence of Ecto-nucleoside triphosphate diphosphohydrolase activity on Trypanosoma cruzi infectivity and virulence.

Authors:  Ramon F Santos; Marcela A S Pôssa; Matheus S Bastos; Paulo M M Guedes; Márcia R Almeida; Ricardo Demarco; Sergio Verjovski-Almeida; Maria T Bahia; Juliana L R Fietto
Journal:  PLoS Negl Trop Dis       Date:  2009-03-03

5.  Purinergic Antagonist Suramin Aggravates Myocarditis and Increases Mortality by Enhancing Parasitism, Inflammation, and Reactive Tissue Damage in Trypanosoma cruzi-Infected Mice.

Authors:  Rômulo D Novaes; Eliziária C Santos; Marli C Cupertino; Daniel S S Bastos; Andréa A S Mendonça; Eduardo de Almeida Marques-da-Silva; Sílvia A Cardoso; Juliana L R Fietto; Leandro L Oliveira
Journal:  Oxid Med Cell Longev       Date:  2018-09-30       Impact factor: 6.543

Review 6.  Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.

Authors:  Chiara Urbinati; Paola Chiodelli; Marco Rusnati
Journal:  Molecules       Date:  2008-11-06       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.